US Patent Issued to Prometheus Biosciences on Sept. 22 for "Therapeutic agents targeting GPR35" (California Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,968, issued on Sept. 22, was assigned to Prometheus Biosciences Inc. (San Diego).

"Therapeutic agents targeting GPR35" was invented by Robert Higuchi (San Diego) and Michael Bishop (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds of Formula Ior a pharmaceutically acceptable salt thereof. The compounds of Formula Lact as GPR35 modulators and can be useful in preventing, treating or acting as a remedial agent for GPR35 related diseases, disorders or conditions."

The patent was filed on Jan. 20, 2023, under Application No. 18/157,686.

*For further information, including images, charts and tables, please visit:...